Skip to content

DoctUro

Active
Private limited company· 3 yrs active
Stallestraat 292 ·1180 Ukkel, Belgium
KBO/BCE: BE 0799.897.929
Watch Print / PDF
Age3 yrs

Summary

Conclusion

the dossier summarised in one paragraph

The computed 12-month bankruptcy probability of DoctUro is 4.7% (elevated). The 2025 annual accounts show equity of €87k and a net result of €104k. Its solvency ranks better than 41% of 2209 sector peers (fiscal year 2025). The company has been active since 2023 and the Belgian State Gazette contains no insolvency or warning signals.

Based on the State Gazette, CBE and 2 annual accounts.

Bankruptcy probability (12 mo)

Checked model v1 · free for everyone
4.7% Elevated
0%0,5%1,5%4%10%≥25%
Young company +No NACE activity registered +Higher-failure-rate region +

Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?

Signals

1 signal · with evidence
Consistently profitable
Positive net result in the two most recent financial years (2024 and 2025).
View the result trend

Signals are derived from the filed annual accounts and the sector comparison. No composite score: each signal is separately verifiable at the source.

Filing behaviour

From the deposit records, complete market-wide
Latest accounts filed on time
The financial year that closed on 30-06-2025 was due by 31-01-2026 and was filed on 30-01-2026, 1 days ahead of the deadline. This speaks to administrative punctuality and says nothing about the financial position.
The next deadline is still running
The next financial year closes on 30-06-2026 and is due by 31-01-2027. Nothing is late today.
How we compute the deadline
The year end is derived from 2 filed financial years, each closing on 30-06. The statutory deadline is seven months after the close of the financial year (art. 3:10 par. 1 CAC, art. 3:47 par. 7 for ASBL and foundations). Applied to the financial year that closed on 30-06-2025, that is 31-01-2026.
Deadline per financial year
Year closed Due by Filed Variance Reference
30-06-2025 31-01-2026 30-01-2026 1 d early 2026-00032424
30-06-2024 31-01-2025 16-01-2025 15 d early 2025-00005681

Source: the National Bank's deposit records. Those records are complete, including for years whose figures we have not read yet. Filing late covers nearly half the market and is therefore not scored; only not filing, being more than 90 days late and breaking a punctual record carry weight.

Trust signals

2 signals
More than 3 years active
Founded in 2023, past the statistically most fragile first 3 years.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad, and the KBO register records a normal legal situation.

Administrative Flags

No strikeouts found in the KBO publications we processed. That series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.

Financials

TurnoverNot published (abbreviated filing)
EBIT marginNot published (abbreviated filing)
Net result€104k+0.6%
Working capital€82k-19.3%

Annual accounts & ratios

Source: NBB · 2025
Annual accounts filed on 30-01-2026 with the NBB · fiscal year 2025 · micro
€0€50k€100k€150kOperating result 2024: €133k€133kNet result 2024: €104k€104kOperating result 2025: €135k€135kNet result 2025: €104k€104k20242025
Operating resultNet result
Sector comparison
Fiscal year 2025 · NACE 86, Human health · compared within the same schema type (micro schema)
Metric This company Sector median Position in the sector
Solvency 42.4% 58.2%
better than 41% of 2209 sector peers
Net result €104k €60k
better than 71% of 2207 sector peers
Equity €87k €74k
better than 54% of 2209 sector peers
Gross operating margin €137k €96k
better than 65% of 2209 sector peers
Total assets €205k €187k
better than 54% of 2209 sector peers
Median and position computed from NBB annual accounts filed by sector peers; own figures from the latest filed accounts.
EBITDA
€137k
-0.6% 24-25
Net profit
€104k
+0.6% 24-25
Cash flow
€106k
-1.7% 24-25
Total assets
€205k
+69.6% 24-25
Equity
€87k
-18.6% 24-25
Working capital
€82k
-19.3% 24-25
Income taxes
€29k
+0.6% 24-25
Dividends
€124k
- 24-25
Debt
€118k
+731.7% 24-25
Debt ≤ 1y
€118k
+731.7% 24-25
Current ratio
1.69
-79.2% 24-25
Quick ratio
1.69
-79.2% 24-25
Solvency
42.4%
-52.0% 24-25
Debt / equity
1.36
+921.3% 24-25
ROE
120.1%
+23.5% 24-25
ROA
50.9%
-40.7% 24-25
Interest coverage
65.84
-56.3% 24-25
Figures by fiscal year
Fiscal year2025
Depositmicro
Revenue-
EBITDA€137k
Net profit€104k
Cash flow€106k
Staff costs-
Income taxes€29k
Dividends€124k
Total assets€205k
Equity€87k
Debt€118k
of which ≤ 1y€118k
of which > 1y-
Working capital€82k
Employees (FTE)-
Ratios (computed)
2025
Current ratio1.69
Quick ratio1.69
Working capital ratio39.9%
Solvency42.4%
Debt / equity1.36
Long-term debt ratio-
Interest coverage65.84
Gross margin-
Net margin-
ROA50.9%
ROE120.1%
EBITDA margin-
Days sales outstanding-
Days payable outstanding-
Inventory turnover-
Days inventory (DSI)-
Balance-sheet composition 2025
Full annual accounts
Filed balance sheet and income statement, exactly as deposited with the NBB.
Line item Code2025
Balance sheet, Assets
TOTAL ASSETS 20/58€205k
Fixed assets 21/28€5k
Tangible fixed assets 22/27€5k
Current assets 29/58€200k
Amounts receivable within one year 40/41€77k
Investments 50/53€18k
Cash & bank 54/58€48k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES 10/49€205k
Equity 10/15€87k
Contributions / capital 10/11€3k
Reserves 13€84k
Amounts payable 17/49€118k
Amounts payable within one year 42/48€118k
Trade debts payable within one year 44€2k
Income statement
Gross operating margin 9900€137k
Operating result 9901€135k
Financial income 75€258
Financial charges 65€2k
Result before taxes 9903€133k
Income taxes 67/77€29k
Net result for the period 9904€104k
Result to be appropriated 9905€104k
You're seeing the latest fiscal year only. Unlock 1 prior year (figures + ratios) with a paid plan. See plans →
Ratios computed by Checked.

Health barometer

FY 2025 · computed
91 / 100 Excellent
050100
Computed from 5 of the 6 factors this model weighs. The rest cannot be derived from the filed figures, or need a prior year to compare against.

Unlock the full score breakdown, per-year score history and the indicative credit limit from Kantoor S.

See plans →
Computed by Checked from the NBB filing for FY 2025. Indicative, not credit advice.

Structure & network

Locations & real estate

Registered office

from the Crossroads Bank
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Stallestraat 2921180 Ukkel

Establishment units

1 location
DoctUro
Ruslandstraat 1, 1060 Sint-Gillis (bij-Brussel)Activiteiten van medisch specialisten
since 20232.343.288.881
Physical sites registered in the Crossroads Bank for Enterprises (CBE).
Parcels2
Ground area1.4 ha
Buildings2
Building footprint3,112 m²
Volume (LiDAR)41,242 m³
Tallest building29.8 m · ±9 fl.

Real-estate footprint

Source: CBE × cadastre · address linking

Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.

Brussels 2 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
21616G0233/00Y000 Brussels 1.3 ha 1 · 2,014 m² 10.0 m · 2 fl.
21562A0388/00B006 Brussels 1,399 m² 1 · 1,098 m² 29.8 m · 9 fl.
Methodology
via registered seat: 1 · via establishment units: 1
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Publications

Lifecycle & Insolvency Signals

No insolvency signals in the Belgian State Gazette

Belgisch Staatsblad · acts

1 acts
Address history · 1
16-09-2025
Registered-office move
All acts · 1 updated 11 months ago
2025
16-09-2025 Registered office moved from Saint-Gilles to Uccle Registered-office change
  • 1060 Saint-Gilles, Rue de Russie boîte 3 → 1180 Uccle, Rue de Stalle 292 boite 76

Analysis

Snowflake analysis

financial profile on 5 axes
Health91Profitability100Solvency80Growth58Stability94
85 / 100

Exceptional profile, strong across almost every axis.

All 5 axes are computed from data Checked has read.

Health 91
Profitability 100
Solvency 80
Growth 58
Stability 94

Ask AI about this company

Checked AI

Soon: ask questions about this dossier, risks, curator, sector comparison, answered from the official data on this page.

TryWhat are the main risks?Any recent red flags?Compare to sector peers
Coming soon

AI due-diligence brief

Checked AI

Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.

Coming soon
The brief is drafted by our AI model at Anthropic in the US, from this dossier's public data. Nothing that identifies you is sent along and we do not keep the brief. Indicative, not legal or investment advice. How it works

Credit advice

verdict per customer and amount

Should this customer buy amount X on invoice? Enter the amount and payment terms, you get an instant GREEN/AMBER/RED verdict, with a suggested ceiling and concrete conditions.

Based on official sources (NBB, CBE, State Gazette). Indicative, not credit advice.

Company registry

Company registry (CBE)

Crossroads Bank
Activities
Activiteiten van medisch specialisten86220
Primary activity highlighted.
Names & trade names
Legal nameFR DoctUro
Registered office
Stallestraat 292 bus 76
1180 Ukkel, Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.